Fluidigm Profit Margin 2008-2019 | FLDM
Current and historical gross margin, operating margin and net profit margin for Fluidigm (FLDM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Fluidigm net profit margin as of September 30, 2019 is -57.1%.
|Fluidigm Annual Profit Margins
|Fluidigm Quarterly Profit Margins
||Medical Instruments Manufacturing
Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California.